Page last updated: 2024-08-26

1-methylpseudouridine and Inflammation

1-methylpseudouridine has been researched along with Inflammation in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Akilli-Öztürk, Ö; Berger, H; Bukur, T; Diken, E; Diken, M; Karikó, K; Kirchhoff, S; Kolb, L; Kranz, LM; Kreiter, S; Krienke, C; Petschenka, J; Sahin, U; Streuber, M; Türeci, Ö; Waisman, A; Yogev, N	1

Other Studies

1 other study(ies) available for 1-methylpseudouridine and Inflammation

Article	Year
A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis. Science (New York, N.Y.), 2021, 01-08, Volume: 371, Issue:6525 Topics: Animals; Antigen-Presenting Cells; Autoantigens; Bystander Effect; Encephalomyelitis, Autoimmune, Experimental; Immunosuppression Therapy; Inflammation; Mice; Mice, Inbred C57BL; mRNA Vaccines; Multiple Sclerosis; Pseudouridine; RNA, Messenger; T-Lymphocytes, Regulatory; Vaccines, Synthetic	2021

Article

Year

A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis.

Science (New York, N.Y.), 2021, 01-08, Volume: 371, Issue:6525

Topics: Animals; Antigen-Presenting Cells; Autoantigens; Bystander Effect; Encephalomyelitis, Autoimmune, Experimental; Immunosuppression Therapy; Inflammation; Mice; Mice, Inbred C57BL; mRNA Vaccines; Multiple Sclerosis; Pseudouridine; RNA, Messenger; T-Lymphocytes, Regulatory; Vaccines, Synthetic

2021